Bumper Offer - Urjas oil Just @ Rs. 1
Gifaxin 200 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Hepatic Encephalopathy. Secondary and off-label uses of Gifaxin 200 Tablet have also been mentioned below.
The correct dosage of Gifaxin 200 Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Gifaxin 200 Tablet include Flatulence, Bloating or fullness, Constipation. While these are the most often observed Gifaxin 200 Tablet side effects, there are can be others also. These have been listed below. These side effects of Gifaxin 200 Tablet are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Gifaxin 200 Tablet's effect is Severe during pregnancy and Severe for lactating mothers. In addition, Gifaxin 200 Tablet's effects on the liver, heart and kidney are discussed below in the Gifaxin 200 Tablet related warnings section.
Other contraindications of Gifaxin 200 Tablet have been discussed in the sections ahead.
Drug interactions for Gifaxin 200 Tablet have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Gifaxin 200 Tablet, it is important to know that it is safe while driving, and is habit-forming.
Gifaxin 200 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| 13 - 18 years (Adolescent) |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Gifaxin 200 Tablet is used -
Moderate
Mild
Common
Is the use of Gifaxin 200 Tablet safe for pregnant women?
Gifaxin shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Gifaxin 200 Tablet safe during breastfeeding?
Gifaxin should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Gifaxin 200 Tablet on the Kidneys?
Gifaxin is not harmful for kidneys.
What is the effect of Gifaxin 200 Tablet on the Liver?
Gifaxin has very mild side effects on the liver.
What is the effect of Gifaxin 200 Tablet on the Heart?
Gifaxin is completely safe for the heart.
Gifaxin 200 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Gifaxin 200 Tablet unless your doctor advises you to do so -
Is this Gifaxin 200 Tablet habit forming or addictive?
Gifaxin 200 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Gifaxin 200 Tablet since it does not cause drowsiness.
Is it safe?
Gifaxin 200 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Gifaxin 200 Tablet is not used to treat mental disorders.
Interaction between Food and Gifaxin 200 Tablet
Taking Gifaxin 200 Tablet with food is safe.
Interaction between Alcohol and Gifaxin 200 Tablet
It is difficult to say anything about the effect of Gifaxin 200 Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
